Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-generation sequencing for the management of sarcomas with no known driver mutations.

Current opinion in oncology - 1 Jul 2021

Vyse Simon, Thway Khin, Huang Paul H, Jones Robin L

Abstract excerpt

PURPOSE OF REVIEW: Next-generation sequencing (NGS) has enabled fast, high-throughput nucleotide sequencing and has begun to be implemented into clinical practice for genomic-guided precision medicine in various cancer types. This review will discuss recent evidence that highlights opportunities for NGS to improve outcomes in sarcomas that have complex genomic profiles with no known driver mutations. RECENT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Genetic Predisposition to Disease
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immune Checkpoint Inhibitors

Share to Immunotherapy

Share to Microsatellite Instability

Share to Precision Medicine

Share to Sarcoma

Source

Identifiers

PMID: 33927108
DOI: 10.1097/CCO.0000000000000741

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-generation sequencing for the management of sarcomas with no known driver mutations.PMID 33927108Read ↗

Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.Semantic proximity Read ↗

Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.Semantic proximity Read ↗

Real-World Implementation of Next-Generation Sequencing in Sarcoma: Molecular Insights and Therapeutic Outcomes.Semantic proximity Read ↗

The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.Semantic proximity Read ↗

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcomaSemantic proximity Read ↗

Molecular Characterization of Soft Tissue Sarcomas Using RNA-Based Next-Generation Sequencing.Semantic proximity Read ↗

Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation SequencingSemantic proximity Read ↗

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.Semantic proximity Read ↗

Distinct genomic landscapes in radiation‐associated angiosarcoma compared with other radiation‐associated sarcoma histologiesSemantic proximity Read ↗

Introduction and impact of routine whole genome sequencing in the diagnosis and management of sarcoma.Semantic proximity Read ↗

Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma PatientsSemantic proximity Read ↗

Unlocking the Potential of ctDNA in Sarcomas: A Review of Recent AdvancesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.